Articles Tagged With:
-
The Many Controversies of Cannabidiol
Current trends in cannabinoid research, federal and state cannabis legislation, multi-sourced information, as well as misinformation, all drive consumer interest in cannabidiol (CBD). With the increased use of CBD products, increased incidents of poisonings are being reported. With confusion on policy, on potential benefits and harms, and on long-term chronic effects often seen with excessive use, determining the facts is increasingly problematic for healthcare practitioners and consumers. These issues prioritize the need for clinicians, especially in primary care, to stay current on developments related to CBD and other cannabinoids.
-
Higher Mortality for Neurosurgery Patients with Pre-Existing DNRs
Neurosurgeons at University of Rochester Medicine observed that patients with pre-existing do-not-resuscitate (DNR) orders receiving cranial neurosurgery tended to have poor outcomes. To see if their clinical observations were reflected in actual data, the neurosurgeons analyzed 30,384 patients who underwent cranial neurosurgery in 2018-2020.
-
Audio Assistance Improves Minorities’ Willingness to Participate in Research
Audio-assisted informed consent forms significantly improved the willingness of a sample of primarily African American patients to participate in a mock clinical trial.
-
It Is Not Just Physicians: Residents also Receive Industry Payments
Drug and device makers publicly report all gifts made to physicians and advanced practice providers, as required by the 2010 Physician Payments Sunshine Act. Residents and other trainees are excluded from this requirement — but that does not mean these providers are not receiving payments.
-
Informed Consent Practices for Acute Stroke Treatment Vary
Currently, the two cornerstones of acute ischemic stroke treatment are intravenous thrombolysis and, for patients with large vessel occlusions, endovascular thrombectomy. For treating clinicians, the question becomes: How do clinicians ensure that patients (or their surrogate decisionmakers) make an informed decision while avoiding treatment delays that can result in worse outcomes?
-
Ethical Decision-Making with Deprescribing for Older Adults
Physicians must consider multiple ethical issues when making decisions on deprescribing for older adults with dementia, a recent study found.
-
Ethical Responses if Faculty Object to Teaching Physician-Assisted Death
Multiple recent papers focus on the ethics of conscious objection of providers participating in medical aid in dying. However, there are little to no recommendations or guidelines for conscientious objection to teaching medical aid in dying.
-
Ethical Input Needed for Digital Models and Simulations in Healthcare
Digital models and simulations are a quickly evolving technology that, like artificial intelligence tools, will change clinical practice and patient care.
-
Unique Ethical Dilemmas for Mental Healthcare of Infants, Young Children
Infant and early childhood mental health practitioners face complex and unique ethical issues. Experts argue that a code of ethics is urgently needed.
-
Ethicists Find that Empathy, Accurate Information Defuse Conflicts
Families may interpret the word “futile” to mean that clinicians are just giving up, that the patient is not important enough to continue the current level of care, or even that clinicians are trying to clear the bed for a more deserving patient.